MEDITE Cancer Diagnostics Inc (MDIT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MEDITE Cancer Diagnostics Inc (MDIT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7123
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrasonic decalcification instruments, tissue processing instruments, freezing microtome, cryostats, linear staining systems, staining systems, and cytology screening systems. The company’s products find application in processing tissue, cell collection ranging from processing to diagnosis. These devices and consumables are manufactured at is facility in Burgdorf, Germany. The company sells its products through a direct sale force located in Germany, Poland and the US, and also through independent distributors. MEDITE is headquartered in Orlando, Florida, the US.

MEDITE Cancer Diagnostics Inc (MDIT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MEDITE Cancer Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
MEDITE Cancer Diagnostics Raises USD0.9 Million in Venture Financing 10
MEDITE Cancer Diagnostics Raises USD1.2 Million in Venture Financing 11
MEDITE Cancer Diagnostics Raises USD0.4 Million in Venture Financing 12
MEDITE Cancer Diagnostics Raises USD0.15 Million in Venture Financing 13
Partnerships 14
Medite To Enter Into Licensing Agreement With Unic Technologies 14
Medite Enters Into Agreement With Anatomical Pathology Company For Coverslipping Film 15
Equity Offering 16
CytoCore Completes First Tranche of Private Placement of Shares for USD1.5 Million 16
Debt Offering 17
MEDITE Cancer Diagnostics Raises USD5.4 Million in Private Placement of Convertible Promissory Notes 17
Acquisition 18
CytoCore Completes Acquisition Of Medite 18
MEDITE Cancer Diagnostics Inc – Key Competitors 19
MEDITE Cancer Diagnostics Inc – Key Employees 20
MEDITE Cancer Diagnostics Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 14, 2017: MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results 22
Corporate Communications 24
Nov 15, 2017: MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board As An Independent Director 24
Nov 08, 2017: MEDITE Cancer Diagnostics Reports Appointments of New Chairman of the Board and Chief Executive Officer 25
Apr 27, 2017: MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer 26
Mar 07, 2017: MEDITE Cancer Diagnostics Appoints Eric M. Goehausen to Board of Directors 27
Product News 28
Jul 27, 2017: MEDITE Cancer Diagnostics to Launch SureCyte C1 Stain Globally at the 29th European Congress of Pathology 28
Other Significant Developments 29
May 10, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 29
Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
MEDITE Cancer Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MEDITE Cancer Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MEDITE Cancer Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MEDITE Cancer Diagnostics Raises USD0.9 Million in Venture Financing 10
MEDITE Cancer Diagnostics Raises USD1.2 Million in Venture Financing 11
MEDITE Cancer Diagnostics Raises USD0.4 Million in Venture Financing 12
MEDITE Cancer Diagnostics Raises USD0.15 Million in Venture Financing 13
Medite To Enter Into Licensing Agreement With Unic Technologies 14
Medite Enters Into Agreement With Anatomical Pathology Company For Coverslipping Film 15
CytoCore Completes First Tranche of Private Placement of Shares for USD1.5 Million 16
MEDITE Cancer Diagnostics Raises USD5.4 Million in Private Placement of Convertible Promissory Notes 17
CytoCore Completes Acquisition Of Medite 18
MEDITE Cancer Diagnostics Inc, Key Competitors 19
MEDITE Cancer Diagnostics Inc, Key Employees 20
MEDITE Cancer Diagnostics Inc, Subsidiaries 21

List of Figures
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[MEDITE Cancer Diagnostics Inc (MDIT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • West Fraser Timber Co. Ltd. (WFT):企業の財務・戦略的SWOT分析
    West Fraser Timber Co. Ltd. (WFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Therapeutic Solutions International Inc (TSOI):医療機器:M&Aディール及び事業提携情報
    Summary Therapeutic Solutions International Inc (Therapeutic Solutions) is a pharmaceutical company that offers supplements. The company offers products such as DermalStilbene, NanoStilbene and ProJuvenol. Its ProJuvenol consists of anti-aging ingredients which helps for a healthy functionality for …
  • Aerostar S.A.:企業の戦略・SWOT・財務情報
    Aerostar S.A. - Strategy, SWOT and Corporate Finance Report Summary Aerostar S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Borders & Southern Petroleum plc (BOR):企業の財務・戦略的SWOT分析
    Summary Borders & Southern Petroleum Plc (Borders & Southern Petroleum) is an oil and gas company that offers exploration and development of hydrocarbons. The company holds interests in three production licenses in the Falkland Islands located south-east of the Islands. Its production licenses provi …
  • Orezone Gold Corporation:企業の戦略・SWOT・財務情報
    Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report Summary Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sanquin Blood Supply Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, an …
  • G-III Apparel Group, Ltd.:企業の戦略・SWOT・財務分析
    G-III Apparel Group, Ltd. - Strategy, SWOT and Corporate Finance Report Summary G-III Apparel Group, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Valener Inc (VNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Valener Inc (Valener) is an investment holding company that focuses on the energy sector. Through its investments in energy portfolio, the company offers storage, distribution, transportation and allied energy services. The company has interest in Gaz Metro and is its limited partner. Gaz Me …
  • C&J Energy Services Inc (CJ):石油・ガス:M&Aディール及び事業提携情報
    Summary C&J Energy Services Inc (C&J) is a provider of onshore well construction, completion, support and other complementary oilfield services. The company offers vertically-integrated suite of services involved in the entire life cycle of the well, including hydraulic fracturing, cased-hole wireli …
  • Iwatani Corp (8088):企業の財務・戦略的SWOT分析
    Iwatani Corp (8088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Phoenix Beverages Limited:戦略・SWOT・企業財務分析
    Phoenix Beverages Limited - Strategy, SWOT and Corporate Finance Report Summary Phoenix Beverages Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Brazil Fast Food Corp.:企業の戦略・SWOT・財務分析
    Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report Summary Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Acura Pharmaceuticals Inc (ACUR)-医療機器分野:企業M&A・提携分析
    Summary Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops, and commercializes tamper-resistant products to prevent the abuse and misuse of medication. The company’s proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tamp …
  • AzurRx BioPharma Inc (AZRX):企業の財務・戦略的SWOT分析
    AzurRx BioPharma Inc (AZRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Success Universe Group Limited
    Success Universe Group Limited - Strategy, SWOT and Corporate Finance Report Summary Success Universe Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Grinners Catering (Australia) Pty Ltd:企業の戦略・SWOT・財務分析
    Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Bio-Rad Laboratories, Inc.:企業の戦略・SWOT・財務情報
    Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Novartis Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG is a developer, manufacturer and distributor of active ingredients, patent protected medicines and treatments for the healthcare industry. The company’s products include innovative prescription medicine and drugs, tablets, …
  • Clarion Co Ltd (6796):企業の財務・戦略的SWOT分析
    Clarion Co Ltd (6796) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Otsuka Holdings Co Ltd (4578):企業の財務・戦略的SWOT分析
    Otsuka Holdings Co Ltd (4578) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆